CLINICAL TRIAL TO DOCUMENT THE IMMUNOGENICITY AGAINST HEPATITIS B OF TWO VERSUS THREE DOSES OF THE VACCINE, WHEN ADMINISTERED TO CHILDREN AGED 2 TO 18 MONTHS

Registry ID

11022017

Source registry

HEALTH_CANADA

Status

Ongoing

Study type

INTERVENTIONAL

Sponsor

CHU DE QUÉBEC-UNIVERSITÉ LAVAL

Start date

2018-01-09

Last update

2017-12-22

Conditions

• HEPATITIS B

View on source registry